Segregation of COPI-rich and anterograde-cargo-rich domains in endoplasmic-reticulum-to-Golgi transport complexes  by Shima, David T. et al.
Brief Communication 821
Segregation of COPI-rich and anterograde-cargo-rich domains in
endoplasmic-reticulum-to-Golgi transport complexes
David T. Shima*, Suzie J. Scales†‡, Thomas E. Kreis† and Rainer Pepperkok§
Membrane traffic between the endoplasmic reticulum
(ER) and the Golgi complex is regulated by two vesicular
coat complexes, COPII and COPI. COPII has been
implicated in the selective packaging of anterograde
cargo into coated transport vesicles budding from the
ER [1]. In mammalian cells, these vesicles coalesce to
form tubulo-vesicular transport complexes (TCs), which
shuttle anterograde cargo from the ER to the Golgi
complex [2–4]. In contrast, COPI-coated vesicles are
proposed to mediate recycling of proteins from the
Golgi complex to the ER [1,5–7]. The binding of COPI to
COPII-coated TCs [3,8,9], however, has led to the
proposal that COPI binds to TCs and specifically
packages recycling proteins into retrograde vesicles for
return to the ER [3,9]. To test this hypothesis, we tracked
fluorescently tagged COPI and anterograde-transport
markers simultaneously in living cells. COPI
predominated on TCs shuttling anterograde cargo to the
Golgi complex and was rarely observed on structures
moving in directions consistent with retrograde
transport. Furthermore, a progressive segregation of
COPI-rich domains and anterograde-cargo-rich domains
was observed in the TCs. This segregation and the
directed motility of COPI-containing TCs were inhibited
by antibodies that blocked COPI function. These
observations, which are consistent with previous
biochemical data [2,9], suggest a role for COPI within
TCs en route to the Golgi complex. By sequestering
retrograde cargo in the anterograde-directed TCs, COPI
couples the sorting of ER recycling proteins [10] to the
transport of anterograde cargo.
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Results and discussion
Microinjection of Cy3-conjugated monovalent Fab frag-
ments of CM1A10 [11], a monoclonal anti-COPI antibody,
into living cells, or ectopic expression of ε-COP tagged with
green fluorescent protein (ε-COPGFP), resulted in the
labelling of distinct peripheral structures that contained
endogenous COPI (see Supplementary material). Neither
Cy3–CM1A10 nor ε-COPGFP interfered with the transport
kinetics of a secretory marker, a temperature-sensitive form
of the vesicular stomatitis virus glycoprotein (ts-O45-G)
from the ER to the plasma membrane. Expression of
ε-COPGFP rescues the temperature-sensitive secretory
transport block in ldlF cells caused by a point-mutation in
ε-COP [12], demonstrating that ε-COPGFP can functionally
substitute for wild-type ε-COP (see Supplementary mater-
ial). Thus, Cy3–CM1A10 and ε-COPGFP can both be used
as faithful markers of COPI in vivo.
The dynamics of fluorescently labelled COPI-containing
structures in living cells were characterized and quantified
using time-lapse microscopy. Of all COPI-coated structures
that were detectable at the beginning of the 2 minute
observation period, 34 ± 6% had saltatory movements,
which lasted 1–2 seconds and had an estimated peak speed
of 2–3 µm/second. Because these movements were
directed towards the Golgi complex (Figure 1a,b and Sup-
plementary material), such structures were termed antero-
grade-directed COPI-containing TCs. Another ~10% of the
COPI-containing TCs typically underwent a series of rapid
looping movements, resulting in repetitive tracking within
a confined region of the cell periphery (see Supplementary
material). Surprisingly, less than 5% of COPI-containing
structures arose on the surface of the Golgi complex and
moved towards the cell periphery, a direction that is consis-
tent with retrograde transport. These structures almost
invariably returned to the Golgi complex, usually on a dis-
tinct trajectory (Figure 1a,c and Supplementary material).
In contrast to anterograde-directed COPI-containing TCs,
which frequently moved long distances (> 10 µm), these
retrograde-directed COPI-containing TCs travelled short
distances (< 5 µm) and rarely reached the cell periphery.
Anterograde, retrograde and looping COPI-containing TCs
all moved at a similar average speed of around
1 µm/second. Approximately 15% of the COPI-coated
structures did not move significantly (> 2 µm) within the
observation period and about 35% disappeared from the
focal plane, thus preventing further analysis.
The unexpected prevalence of COPI-coated structures
moving towards rather than away from the Golgi complex
was not an artefact of Cy3–CM1A10 binding, because
COPI-containing TCs labelled with ε-COPGFP showed
identical behaviour (see Supplementary material).
To investigate the relationship between COPI-containing
TCs and secretory cargo in living cells, two GFP-tagged
anterograde transport markers, ts-G-GFPct [13] and a trun-
cated version of the Golgi-resident enzyme N-acetylglu-
cosaminyltransferase I (NAGFP [13]), which are
transported vectorially from the ER to the Golgi, were
expressed and co-visualised with Cy3–CM1A10 in living
Vero cells. On shifting to the permissive temperature of
31°C, ts-G-GFPct rapidly accumulated in TCs that moved
towards the Golgi complex, as previously described [3,4].
Over 90% of these TCs were continuously labelled with
Cy3–CM1A10 during their entire journey (Figure 1d,e).
In contrast, only 60% of Cy3-labelled COPI-containing
TCs were also labelled with ts-G-GFPct at any given time,
suggesting that not all the COPI-containing TCs transport
ts-G-GFPct, in agreement with previous results obtained
in fixed cells [14,15]. Similar results were obtained using
newly synthesised NAGFP, which was also rapidly trans-
ported from the ER to the Golgi complex in COPI-coated
TCs (see Supplementary material). 
As expected, ts-G-GFPct was not present in COPI-con-
taining TCs but was retained in the ER when cells were
incubated at 39.5°C. Neither was it found in COPI-con-
taining TCs when it was in transit from the trans-Golgi
network to the plasma membrane, and was never found
in retrograde COPI-containing TCs, suggesting that
these are not directly involved in ts-G-GFPct transport
(data not shown).
Closer analysis of the distributions of COPI and secretory
cargo in living cells revealed that ts-G-GFPct often
labelled the end of the moving TCs that faced the Golgi
complex, whereas COPI localised predominantly to the
opposite end (Figure 2a–c). By measuring the relative
intensities of GFP and Cy3 fluorescence across TCs, the
distribution of COPI was shown to overlap that of ts-G-
GFPct by, on average, 51 ± 7%, n = 27 (Figure 2f). This
polarised distribution was more pronounced in TCs close
to the Golgi complex and appeared to increase during the
movement of TCs from the cell periphery (60–70%
overlap) to the Golgi complex (< 30% overlap,
Figure 2a,c). Similar results were obtained in fixed cells
immunostained for ts-O45-G and β-COP, and when CD8
was used as the secretory marker (data not shown).
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Figure 1
Direct visualisation of COPI and the
secretory-transport marker ts-G-GFPct in
ER-to-Golgi transport. Vero cells were
microinjected with a Cy3-conjugated anti-
COPI antibody (Cy3–CM1A10) at 37°C and
immediately imaged by time-lapse video
microscopy, using light attenuated 50 times.
Images were acquired every sec for 2 min at
37°C. (a) An overview of one analysed cell.
Red and yellow lines indicate the trajectories
of an anterograde and retrograde COPI-
containing TC, respectively. Starting points
are marked by green dots. Individual images
of (b) the anterograde and (c) the retrograde
COPI-containing TCs highlighted in (a). The
arrows indicate the position of the COPI-
containing TC of interest. ‘QuickTime’ movies
(animations a–c) corresponding to this figure
are available as Supplementary material.
(d,e) Vero cells, in which ts-G-GFPct was
accumulated in the ER by incubation at
39.5°C for 6 h, were injected with
Cy3–CM1A10 at 39.5°C. (d) Ts-G-GFPct and
(e) fluorescently labelled COPI were
visualised by confocal microscopy at 31°C,
with simultaneous image acquisition of the
Cy3 and GFP images at 0.8 sec intervals.
Arrows indicate a COPI-containing TC that
transports ts-G-GFPct to the Golgi complex.
Cy3–CM1A10
















0.8 2.4 4.0 5.6 6.4 7.2
2 16 18 20 24 26 30
14 15
Fixed cells were co-stained with antibodies against COPI
and the KDEL receptor, ERGIC 53 or p23, three mem-
brane proteins cycling between the ER and Golgi complex.
The distributions of these proteins overlapped with COPI
on TCs considerably more than did ts-G-GFPct: 81 ± 7%
for the KDEL receptor, n = 87; 86% ± 4 for ERGIC 53,
n = 47; and 88% for p23, n = 67 (Figure 2d and data not
shown). Co-staining with two distinct COPI antibodies was
used as a control and these overlapped on TCs by 95 ± 4%
(data not shown). These data suggest differential compart-
mentalisation of proteins during TC movement. Similar
distributions of ERGIC 53 and syntaxin 5 relative to COPI
on TCs have been previously reported in fixed cells
[16,17], supporting the proposed role for the TC as a
sorting organelle [18,19]. 
When COPI was inactivated by microinjection of an anti-
β-COP antibody (anti-EAGE), which inhibits ER-to-Golgi
transport [20], the dynamics of COPI-containing and secre-
tory-marker-positive TCs were strongly inhibited (Table 1
and Supplementary material). A similar inhibition of the
dynamics of COPI-containing TCs resulted when cells
were treated with the microtubule-disrupting drug nocoda-
zole for 10 minutes prior to observation (Table 1). The seg-
regation of TCs into domains rich in either COPI or
anterograde cargo was also inhibited by microinjection of
the anti-EAGE antibody (Figure 2e,g) or by incubation of
cells at 15°C, a temperature known to block secretory
transport between the ER and Golgi complex. The overlap
of COPI with ts-G-GFPct on TCs was 84 ± 6% (n = 37) and
89 ± 4% (n = 41), respectively, under these conditions.
Thus, it appears that the segregation of TCs into COPI-
rich domains and anterograde-cargo-rich domains is closely
linked to the dynamics of the TCs. It remains unclear,
however, whether inhibition of TC movement results in
inhibition of segregation or vice versa.
Biochemical and genetic data have provided strong evi-
dence for the role of COPI in the retrieval of proteins from
the Golgi complex to the ER [10,19,21,22], leading to the
concept that COPI vesicles mediate retrograde transport
from the Golgi complex to the ER [1,5–7]. To account for
the localisation of COPI to COPII-containing TCs in
mammalian systems, it has been suggested that COPI-
containing vesicles form from these TCs and mediate
retrieval of ER proteins [3,8,9]. Our data show that the
predominant COPI-labelled structures observed in vivo
are vehicles for the transfer of secretory cargo from the ER
to the Golgi complex. We cannot, however, exclude the
possibility that there is a more substantial pool of retro-
grade-directed COPI-containing vesicles, which are
beyond the limits of detection in our system. But the con-
tinuous association of the COPI coat with the majority
(> 90%) of anterograde-directed TCs and the functional
link between COPI and ER-to-Golgi transport suggests
some role for COPI on anterograde TCs. 
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Figure 2
Distribution of COPI and membrane markers on TCs. (a–c) TCs
double-labelled with ts-G-GFPct (green) and Cy3–CM1A10 (red) in
living cells, corresponding to time-points (a) 0.8 sec, (b) 3.2sec and
(c) 6.4sec of the experiment shown in Figure 1d,e. Arrows point to the
TCs of interest. (d) Confocal images of TCs in fixed cells double-
labelled with antibodies against COPI (red) and the KDEL receptor
(green). (e) TCs labelling positive for ts-G-GFPct (green) in a living cell
microinjected with Cy3–CM1A10 (red) and anti-EAGE. (f,g) Intensity
profiles of the COPI and ts-G-GFPct labelling on the TC marked by an
arrow in (c) and (e), respectively. The green and red lines represent the
profiles for GFP (ts-G-GFPct) and Cy3 (COPI) fluorescence,
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Quantitation of the motility of COPI-containing TCs.
Treatment of cells Number of moving Average displacement
COPI-containing TCs* (µm/min)†
(%)
Control 85.3 ± 10.9 34.8 ± 4.2
Nocodazole 8.3 ± 5.2 3.3 ± 0.15
Injection of 15.2 ± 4.2 5.1 ± 0.25
anti-EAGE‡
*More than 100 COPI-containing TCs in randomly chosen fields from
at least three different cells were followed for 25 sec. They were
scored as moving when they moved further than 2 µm or when they
moved and subsequently left the plane of focus during the observation
period. Data are expressed as mean ± standard deviation (SD). †The
distance travelled by TCs that were followed for at least 25 sec
(n > 50) was determined and expressed as average
displacement ± SD. ‡A corresponding QuickTime movie showing an
example of a cell injected with anti-EAGE is shown in the
Supplementary material. 
Our observations in vivo, when integrated with the avail-
able biochemical and genetic data, suggest that one role
for COPI on ER-to-Golgi TCs is to bind and sequester
proteins destined for retrieval to the ER. This interaction
results in the establishment of distinct retrograde-cargo
and anterograde-cargo domains within the TC itself.
Because we can provide no evidence for COPI-coated
vesicles budding from these moving TCs, we suggest that
following the transport of TCs to the cis-Golgi, anterograde
cargo is delivered for further transit through the secretory
pathway whereas retrograde cargo is packaged for delivery
back to the ER. Establishing whether it is the retrograde-
directed COPI-containing TCs, or other carriers, that are
involved in vectorial transport back to the ER awaits the
development of tools to visualise retrograde cargo in vivo. 
Supplementary material
Supplementary material including QuickTime movies of the results
shown in Figure 1 and Table 1 and additional methodological details is
available at http://current-biology.com/supmat/supmatin.htm.
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Supplementary materials and methods
Cloning of ε-COPGFP
Human brain ε-COP was obtained from I.M.A.G.E.consortium (40054;
Genbank accession number for ε-COP is AJ13118), fused through a
linker (AAEQLISEEDLP) to the amino terminus of a bright-red-shifted
GFP variant [S1], and subcloned into the mammalian vector
pUHD10.3 [S2].
Antibodies 
Mouse monoclonal antibodies against ERGIC 53 [S3], the cytoplasmic
tail of ts-O45-G (P5D4, [S4]), the KDEL receptor (anti-KDEL-R, [S5])
and CD8 [S6], and rabbit polyclonal antibodies against β-COPI (anti-
EAGE [S7]) and β′-COP [S8] were used in the experiments. Mouse
IgG (Cappel) was used as a control. Monovalent Fab fragments of
monoclonal antibody CM1A10 (anti-COPI, [S9]; hybridomas kindly
provided by Jim Rothman) were prepared as described [S7] and sub-
sequently labelled with Cy3 (Amersham) according to the manufactur-
er’s instructions. Labelling efficiency was approximately one
fluorophore per Fab fragment. Anti-p23 antibodies were raised in
rabbits as described [S10].
Quantitation of COPI dynamics and co-localisation
Quantitative analysis of the trajectories of COPI-containing TCs was
performed using an extension to the IPlab software package developed
at the ICRF light microscopy laboratory (obtainable from Imperial
Cancer Technology Transfer Inc. (ICRT)). TCs were categorized as
anterograde-directed or retrograde-directed if they exhibited directed
movement with trajectories ≥ 3 µm and either terminated or were initi-
ated within 1µm of the Golgi ribbon, respectively. The labelling density
profiles of double-labelled TCs were determined using NIH image
version 1.60. Raw images acquired by confocal microscopy were nor-
malized for each colour separately. An average lowpass filter was used
to remove image noise, and then the intensity profile along a line cross-
ing the entire TC was determined for each individual colour and plotted.
Movie 1–3
Direct visualisation of COPI and the secretory transport marker ts-G-
GFPct in ER-to-Golgi transport. These three movies (1–3) accompany
Figure 1a–c, respectively. They are ‘QuickTime’ animations and are
accelerated by a factor of four.
Movie 4
The dynamics of COPI-containing TCs labelled by expression of
ε-COPGFP in living cells. DNA encoding ε-COPGFP was microinjected
into the nuclei of Vero cells and the dynamics of the expressed
ε-COPGFP was analysed 24 h later by time-lapse microscopy.
Movie 5
The dynamics of a COPI-containing TC exhibiting rapid looping move-
ments in the cell periphery of a live Vero cell. 
Movie 6
The motility of COPI-containing TCs in live cells microinjected with an
anti-β-COPI antibody (anti-EAGE). TCs were visualised using
Cy3–CM1A10. The animation accompanies Table 1.
Supplementary material
Figure S1
Fluorescent labelling of COPI in living cells. COPI was fluorescently
labelled in living cells by microinjection of either (a,b,e,f) Cy3-
conjugated monovalent Fab fragments of anti-COPI antibody CM1A10,
or (c,d) a plasmid encoding ε-COPGFP. Cells were fixed (a,b) 30 min or
(c,d) 12 h after microinjection and immunostained with anti-β-COP
antibodies (b,d). Arrowheads indicate overlapping structures, whereas
arrows indicate non-overlapping structures. The insets show the
respective areas of interest magnified 2.5 times. (e,f) Vero cells were
injected with Cy3–CM1A10 either (f) with or (e) without GTPγS and
fixed 10 min later. Arrows in (e) indicate TCs typically labelled by
Cy3–CM1A10 in living or fixed cells. The arrowhead indicates a larger
structure in the region of the Golgi complex. Arrowheads in (f) point to
the numerous distinct COPI-positive structures resulting from GTPγS
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Figure S3
Simultaneous visualisation of COPI and the
secretory marker NAGFP in ER-to-Golgi
transport. Vero cells were microinjected with a
plasmid encoding the GFP-tagged Golgi
resident enzyme NAGTI (NAGFP [S12]). After
45 min, cells were injected with
Cy3–CM1A10 and immediately observed by
time-lapse video microscopy for 3 min.
Sequential images of NAGFP and Cy3-
CM1A10 were acquired every 3 sec. The
arrowhead and arrow indicate two COPI-
containing TCs that carry NAGFP to the Golgi
complex. The scale bar represents 15 µm.
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Figure S2
Rate of appearance of ts-O45G at the plasma membrane is not
affected in cells containing fluorescently labelled COPI. (a) Vero cells
were infected at 39.5°C with ts-O45 for 2.5 h, subsequently injected
at 39.5°C with control mouse IgGs (filled diamonds), Cy3–CM1A10
(filled circles) or were not injected (open diamonds), and then shifted
to the permissive temperature of 31°C for different times before
fixation and immunostaining for cell-surface ts-O45-G. The appearance
of ts-O45-G at the cell surface was quantified as described [S7,S11]
and plotted as the averages ± SD of two independent experiments
(n > 60 cells for each experiment); the data are normalised to the
surface fluorescence in control IgG-injected cells at 60 min. (b) Vero
cells were injected with ts-G-GFPct DNA and incubated for 6 h at
39.5°C to accumulate ts-G-GFPct in the ER. They were then injected
with Cy3–CM1A10 and immediately observed by confocal time-lapse
microscopy at 31°C for 3 min. Images were acquired at 1 sec intervals
using light attenuated 50 times (data not shown). The cells were then
left unperturbed for a further 75 min to allow ts-G-GFPct to move
completely to the cell surface, fixed and then processed for surface ts-
045-G fluorescence. Asterisks indicate injected cells. The scale bar
represents 15 µm. (c) ldlF cells were injected with ts-G-GFPct either
alone (filled circles), or in combination with ε-COPGFP (open squares)
and compared to wild-type CHO cells injected with ts-G-GFPct (open
circles). Cells were incubated for 12 h at 39.5°C to allow ts-G-GFPct
to accumulate in the ER and for the degradation of endogenous
ε-COP in ldlF cells. The temperature was then shifted to 31°C in the
presence of cycloheximide for the indicated times, and cells were fixed
and immunostained for ts-G-GFPct at the plasma membrane. The data
were normalised to 0% at 0 min and 100% for the brightest cell in
each set of experiments. Data are expressed as mean ± SD from 2–3
independent experiments (n > 120 cells per time-point).
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